Happiness

Advancing Transformational Innovation in HIV Research: A Pillar of Gilead’s Efforts to Help End the Global HIV Epidemic

Gilead scientists engaging in research activity in laboratory

(Image credit: Gilead)

It has been more than 40 years since the first reported cases of HIV, and tremendous progress has been made toward ending the epidemic, including advances in HIV treatment that allow for longer and healthier lives. Nevertheless, HIV persists as a serious public health challenge. In the United States, the South accounts for eight of the top ten states and nine of the top ten metropolitan areas with the highest rates of new infections. Globally, it’s estimated that more than 36 million people are living with HIV and 4000 individuals are newly infected each day, with the burden disproportionately faced by Sub-Saharan Africa and many low- and middle-income countries. Scaling up proven prevention interventions and strategies is essential to reduce the individual and societal burden of the virus. The HIV epidemic is not over.

The work needed to overcome the epidemic includes an unequivocal commitment to continued scientific innovation to provide solutions for the unmet and evolving needs of people around the world. Scientific breakthroughs and medical innovations have brought radical change for people and communities most affected by HIV. The advent of antiretroviral therapy and once-daily single tablet regimens represent some of the most significant milestones that have helped bring radical change in the outlook for people affected by HIV. The scientific advancements have been transformative but significant gaps in care remain. 



Source link

Leave a Reply

Your email address will not be published.